The 2021 Medtech Contract Manufacturing Report

innovation hub

DiagnOptics is Profiled in this Database

Updated At 02 Feb, 2012

Start Free 7 Day Trial Now
Partial description of this company
Technology that provides an immediate cardiovascular risk prediction for major chronic diseases, such as diabetes. The method is convenient, easy-to-use, and validated. It measures tissue accumulation of Advanced Glycation End products (AGEs) by means of fluorescence techniques. AGEs play a key role in the pathogenesis of many age-related diseases, such as diabetes and cardiovascular disease.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of DiagnOptics plus 4858 other startups.

Start Free 7 Day Trial Now

Learn More About DiagnOptics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation


Our Clients